渗透疗法对瞳孔反应性的影响:应用瞳孔测量法在危重神经患者中的定量评估
该研究为两中心研究,纳入神经科学重症监护室72例次入院、403对瞳孔观察,在给予20%甘露醇或23.4%高渗盐水前后2小时内进行定量瞳孔测量。主要终点神经瞳孔指数(NPi,0-5分,>3为正常)在控制其他常用干预后显著改善(β=0.08,p=0.0168),在干预前NPi异常的患者中效应更明显(β=0.57,p=0.0235)。结论提示渗透疗法可改善异质性危重人群的瞳孔反应性,未来需确定剂量依赖效应和临床效用。
要点
- 在控制其他常用干预后,全队列渗透疗法后2小时内NPi显著改善(β=0.08,p=0.0168)。
- 干预前NPi异常的患者中效应最明显(β=0.57,p=0.0235)。
- 研究纳入两中心神经科学重症监护室72例次入院、403对瞳孔观察,使用20%甘露醇或23.4%高渗盐水。
- NPi为0-5分复合指标,>3分视为正常。
- 作者认为未来需确定剂量依赖效应和临床效用。
适用人群与场景
- 两中心神经科学重症监护室中,在给予20%甘露醇或23.4%高渗盐水前后2小时内记录有定量瞳孔测量的患者。
诊断标准与关键阈值
- 神经瞳孔指数(NPi)为0-5分复合指标,>3分视为正常。
处置流程与药物剂量
- 给予20%甘露醇或23.4%高渗盐水(原文未写明剂量、给药途径、频次或疗程)。
研究设计与关键结果
- 研究类型为两中心研究,纳入72例次入院(403对瞳孔观察),在神经科学重症监护室给予20%甘露醇或23.4%高渗盐水前后2小时内进行定量瞳孔测量。
- 主要终点:控制其他常用干预后,全队列渗透疗法后2小时内NPi显著改善(β=0.08,p=0.0168)。
- 在干预前NPi异常的患者中效应最明显(β=0.57,p=0.0235)。
证据类型、等级与局限
- 证据类型:研究论文(两中心研究)。
- 局限:原文未报告局限性;作者在结论中指出未来需确定剂量依赖效应和临床效用。
对床旁实践的改变
- 作者认为渗透疗法后瞳孔反应性显著改善,尤其基础NPi异常者;未来需确定剂量依赖效应和临床效用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Osmotic therapy is a critical component of medical management for cerebral edema. While up to 90% of neurointensivists report using these treatments, few quantitative clinical measurements guide optimal timing, dose, or administration frequency. Its use is frequently triggered by a qualitative assessment of neurologic deterioration and/or pupil size, and anecdotally appears to improve pupil asymmetry suggestive of uncal herniation. However, subjective pupil assessment has poor reliability, making it difficult to detect or track subtle changes. We hypothesized that osmotic therapy reproducibly improves quantitative pupil metrics.
METHODS: We included patients at two centers who had recorded quantitative pupil measurements within 2 h before and after either 20% mannitol or 23.4% hypertonic saline in the neurosciences intensive care unit. The primary outcome was the Neurologic Pupil Index (NPi), a composite metric ranging from 0 to 5 in which > 3 is considered normal. Secondary outcomes included pupil size, percent change, constriction and dilation velocity, and latency. Results were analyzed with Wilcoxon signed-rank tests, Chi-square and multi-level linear regression to control for other edema-reducing interventions.
RESULTS: Out of 72 admissions (403 paired pupil observations), NPi significantly differed within 2 h of osmotic therapy when controlling for other commonly used interventions in our whole cohort (β = 0.08, p = 0.0168). The effect was most pronounced (β = 0.57) in patients with abnormal NPi prior to intervention (p = 0.0235).
CONCLUSIONS: Pupil reactivity significantly improves after osmotic therapy in a heterogenous critically ill population when controlling for various other interventions. Future work is necessary to determine dose-dependent effects and clinical utility.
参考来源
- Ong C, Hutch M, Barra M, et al. Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients. Neurocrit Care. 2019. PMID: 30298336. doi:10.1007/s12028-018-0620-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。